The rating affirmation is based on several factors, including CHCO’s continued strong operating performance, nationally ranked clinical offerings and favorable market position.
The outlook is stable, reflecting Moody’s Investors Service’s expectation that cash flow and cash balances will continue to grow at a rate sufficient to absorb CHCO’s very high level of leverage.
More articles on healthcare finance:
Michigan hospital set to lose Medicare status over patient suicide
This week’s 5 must-reads for hospital CFOs
8 healthcare CFOs in the headlines
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
